title: Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.
authors.affiliation: Laboratory of Functional Neurochemistry, Neurological Institute C. Mondino, Via Palestro, 3 27100 Pavia, Italy. fabio.blandini@mondino.it
authors.forename: F
authors.initials: F
authors.lastname: Blandini
authors.forename: R
authors.initials: R
authors.lastname: Fancellu
authors.forename: E
authors.initials: E
authors.lastname: Martignoni
authors.forename: A
authors.initials: A
authors.lastname: Mangiagalli
authors.forename: C
authors.initials: C
authors.lastname: Pacchetti
authors.forename: A
authors.initials: A
authors.lastname: Samuele
authors.forename: G
authors.initials: G
authors.lastname: Nappi
mesh_terms: D000978:Antiparkinson Agents / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives / Q000097:blood; D004298:Dopamine / Q000097:blood; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007980:Levodopa / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D014443:Tyrosine / Q000031:analogs & derivatives
chemical_list: D000978:Antiparkinson Agents; D006710:Homocysteine; D014443:Tyrosine; D007980:Levodopa; D004295:Dihydroxyphenylalanine; C008404:3-methoxytyrosine; D004298:Dopamine